Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Basel

Biotech Outsourcing Strategies Basel 2025

The Biotech Outsourcing Strategies event facilitates the exchange of expertise, the strengthening of current outsourcing collaborations, and the establishment of new business connections between buyers [...]

Basel

Discovery & Development Europe 2025

Be part of the renowned Discovery & Development Summit in Basel, uniting 1000+ leaders in biology and chemistry to connect, collaborate, and accelerate the development [...]

Basel

SGPP Annual Congress/PSY Congress 2025

"Psyche, Human, Brain – Psychiatry at the Center" forms the central theme of the 2025 edition. The program promises insightful keynote speeches and state-of-the-art presentations [...]

Go to Top